首页> 外国专利> Detection method and its use of the epitope of the allergen or the candidate

Detection method and its use of the epitope of the allergen or the candidate

机译:过敏原或候选抗原表位的检测方法及其用途

摘要

The disclosure herein provides a method of detecting a set of epitopes of two or more allergens in one. According to the disclosure herein, Upon detecting the candidate epitope or allergen, and the test sample group as (a) test sample containing antibodies from allergic positive individuals of multiple allergies negative individuals multiple the array per each of the control sample group containing an antibody that is derived from, overlapping peptides plurality of predetermined length based on the amino acid sequence or a portion thereof allergenic protein potential is fixed, the samples of each group supplies respectively, by contacting the antibody of said one or more with overlapping peptides of the plurality, each overlapping peptides of said plurality, detecting specific binding of the antibodies of said one or more and, there is overlapping peptide selected from the overlapping peptides of the plurality, is obtained from the test sample groups and the average control strength information about the intensity of the specific binding of the overlapping peptides derived from the control sample group or a first epitope of the allergen, the overlapping peptides of one or more on the basis of the average test intensity information about the intensity of the specific binding of the overlapping peptides, the specific binding is positive and the candidate relates test sample is selected from the test sample group, and the average control strength information and the test intensity information of the individual of the overlapping peptides corresponding to the candidate or a first epitope of said one or more When it can be based on the door, and the candidate epitope or first the overlapping peptides from the overlapping peptide other candidate other than the epitope or said first, and based on the average control strength information I want to be with the candidate or second epitope in the allergen the overlapping peptides of one or two or more with the individual test strength information that exceeds the critical value or greater than a value obtained Te.
机译:本文的公开内容提供了一种检测一种或多种变应原的一组表位的方法。根据本文的公开内容,在检测到候选表位或变应原后,测试样品组为(a)包含来自多个过敏阴性个体的过敏阳性个体的抗体的测试样品,每个包含抗体的对照样品组的阵列倍增,衍生自基于氨基酸序列或其一部分的预定长度的多个预定长度的重叠肽,所述变应原蛋白潜力是固定的,通过使所述一个或多个抗体与所述多个重叠肽接触,分别提供每个组的样品,从所述测试样品组和关于强度的平均对照强度信息获得所述多个复数个重叠肽中的每一个的重叠肽,检测所述一种或多种抗体的特异性结合,并且存在选自多个复数个重叠肽中的重叠肽。来源于contr的重叠肽的特异性结合在样品组或变应原的第一表位中,一个或多个重叠肽基于关于重叠肽特异性结合强度的平均测试强度信息,特异性结合为阳性并且候选物与测试样品相关从测试样品组中选择,并且对应于所述一个或多个候选者或第一表位的重叠肽的个体的平均控制强度信息和测试强度信息可以基于门,并且候选表位或第一个重叠肽,而不是该表位或所说的第一个以外的其他候选肽,并基于平均控制强度信息,我希望与变应原中的候选表位或第二个表位一起存在,一个或两个或两个超过临界值或大于获得的Te的值的单个测试强度信息会产生更多的影响。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号